Search results for

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.

For some Christians in the U.S., the 2020 Covid lockdowns fueled the belief that they were being politically persecuted, prompting them to now resolve to "take back" America as the election nears.

Senate Minority Leader Mitch McConnell is criticizing the Republican National Committee for censuring two House Republicans who serve on the panel investigating the U.S. Capitol insurrection.

Getting enough sleep is as crucial as eating well and exercising. But with family life spinning faster and faster, solid shut-eye is sometimes hard to come by. That can hurt kids' health — and increase their weight.

Most public schools are unlikely to feel the effects of the sequester before September. But educators and administrators nationwide are worried they may be forced to cut Head Start enrollment, after-school programs, reading coaches and even teachers when those budget reductions hit.

A civil lawsuit that shifted into U.S. district court in Idaho last week alleges that the United Potato Growers of America has become a veritable OPEC of spuds. The group is accused of using high-tech, strong-arm tactics to inflate potato prices.

With possession of small amounts of pot about to be decriminalized in Washington State, Seattle's finest went to the Web to explain what's going to happen. Bilbo and Gandalf from Lord of the Rings help set the cool mood.

The tax overhaul uses an alternative measure of inflation that will show less upward pressure on prices. That means tax brackets will adjust upward less often, making many people pay more.

Steve Inskeep talks to Rep. John Shadegg (R-AZ), the latest to jump into the race to succeed Tom DeLay as House majority leader. Though Shadegg also accepted money from lobbyist Jack Abramoff, he insists he's more committed to reform than his two main rivals -- the current acting majority leader Roy Blunt (R-MO) and John Boehner (R-OH).

Federal health officials are convening with outside advisers April 6 to talk about a vaccine plan, whether that's another booster in the fall, an omicron shot or one that targets more than one strain.